Contrast-enhanced MR cholangiography: Comparison of Gd-EOB-DTPA and Mn-DPDP in healthy volunteers

British Journal of Radiology

Volumn 85, Issue 1017, 2012, Pages 1250-1254

  Bae, K ^a   Na, J B ^a   Choi, D S ^a   Cho, J M ^a   Choi, H C ^a   Jeon, Kyung Nyeo ^a   Park, M J ^a   Choi, H Y ^a   Kim, J E ^a   Chung, S H ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; MANGAFODIPIR;

ADULT; ARTICLE; BILE DUCT; CHOLANGIOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST TO NOISE RATIO; FEMALE; HEPATIC DUCT; HUMAN; INTERMETHOD COMPARISON; LIVER; MAGNETIC RESONANCE CHOLANGIOGRAPHY; MALE; MATHEMATICAL PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL NOISE RATIO;

ADULT; BILE DUCTS; CHOLANGIOGRAPHY; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; EDETIC ACID; FEMALE; GADOLINIUM DTPA; HUMANS; MALE; PYRIDOXAL PHOSPHATE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84866061768     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/22238911     Document Type: Article

References (25)

1. Irie H, Honda H, Tajima T, Kuroiwa T, Yoshimitsu K, Makisumi K, et al. Optimal MR cholangiopancreatographic sequence and its clinical application. Radiology 1998;206:379-87.
2. Varghese JC, Liddell RP, Farrell MA, Murray FE, Osborne H, Lee MJ. The diagnostic accuracy of magnetic resonance cholangiopancreatography and ultrasound compared with direct cholangiography in the detection of choledocholithiasis. Clin Radiol 1999;54:604-14.
3. Hintze RE, Adler A, Veltzke W, Abou-Rebyeh H, Hammerstingl R, Vogl T, et al. Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 1997;29:182-7.
4. Mitchell DG, Alam F. Mangafodipir trisodium: effects on T2- and T1-weighted MR cholangiography. J Magn Reson Imaging 1999;9:366-8.
5. Lee VS, Rofsky NM, Morgan GR, Teperman LW, Krinsky GA, Berman P, et al. Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy. AJR Am J Roentgenol 2001;176:906-8.
6. Carlos RC, Hussain HK, Song JH, Francis IR. Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol 2002;179:87-92.
7. Laurent V, Corby S, Barbary C, Kermarrec E, Beot S, Regent D. New possibilities to study biliary tree and gallbladder: functional magnetic resonance cholangiography contrast-enhanced with mangafodipir trisodium (Mn DPDP). [In French.] J Radiol 2007;88:531-40.
8. Fayad LM, Holland GA, Bergin D, Iqbal N, Parker L, Curcillo PG 2nd, et al. Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography. J Magn Reson Imaging 2003;18:449-60.
9. Lee VS, Krinsky GA, Nazzaro CA, Chang JS, Babb JS, Lin JC, et al. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium- enhanced MR cholangiography versus conventional T2-weighted MR cholangiography. Radiology 2004;233:659-66.
10. Kirchin MA, Pirovano GP, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 1998;33:798-809.
11. Wang C, Gordon PB, Hustvedt SO, Grant D, Sterud AT, Martinsen I, et al. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol 1997;38:665-76.
12. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-92.
13. Schuhmann-Giampieri G, Mahler M, Roll G, Maibauer R, Schmitz S. Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans. J Clin Pharmacol 1997;37:587-96.
14. Soto JA, Alvarez O, Munera F, Velez SM, Valencia J, Ramirez N. Diagnosing bile duct stones: comparison of unenhanced helical CT, oral contrast-enhanced CT cholangiography, and MR cholangiography. AJR Am J Roentgenol 2000;175:1127-34.
15. Becker CD, Grossholz M, Becker M, Mentha G, de Peyer R, Terrier F. Choledocholithiasis and bile duct stenosis: diagnostic accuracy of MR cholangiopancreatography. Radiology 1997;205:523-30.
16. Irie H, Honda H, Kuroiwa T, Yoshimitsu K, Aibe H, Shinozaki K, et al. Pitfalls in MR cholangiopancreatographic interpretation. Radiographics 2001;21:23-37.
17. Gazelle GS, Lee MJ, Mueller PR. Cholangiographic segmental anatomy of the liver. Radiographics 1994;14:1005-13.
18. Gallez B, Baudelet C, Adline J, Charbon V, Lambert DM. The uptake of Mn-DPDP by hepatocytes is not mediated by the facilitated transport of pyridoxine. Magn Reson Imaging 1996;14:1191-5.
19. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1991;22:233-7; discussion: 242.
20. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183:59-64.
21. Elizondo G, Fretz CJ, Stark DD, Rocklage SM, Quay SC, Worah D, et al. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991;178:73-8.
22. Kim KW, Park MS, Yu JS, Chung JP, Ryu YH, Lee SI, et al. Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR cholangiography: preliminary study. Radiology 2003;227:580-4.
23. Carlos RC, Branam JD, Dong Q, Hussain HK, Francis IR. Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol 2002;9:1322-5.
24. Clement O, Muhler A, Vexler V, Berthezene Y, Brasch RC. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Invest Radiol 1992;27:612-19.
25. Takao H, Akai H, Tajima T, Kiryu S, Watanabe Y, Imamura H, et al. MR imaging of the biliary tract with Gd-EOBDTPA: effect of liver function on signal intensity. Eur J Radiol 2011;77:325-9.